Boehringer Allies With Quallent For Push On Adalimumab

Follows Confirmation Of Teva-Alvotech Involvement In Deal With Cigna’s Evernorth

 
• By David Wallace
  
Handshake
Boehringer has announced an adalimumab deal with Quallent
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products